Pfizer and BioNTech

seeks US approval of COVID-19 vaccine for children under 5

eAwaz Medicine

WASHINGTON (AFP) Pfizer and BioNTech said Tuesday they are seeking emergency authorisation from US health regulators for use of their COVID-19 vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorises the two-shot regimen, it will become the first coronavirus vaccine available to this age group in the United States. In a tweet soon after the announcement, the FDA said it will hold a meeting in two weeks, on February 15, to consider the request.